School of Medicine
Showing 681-700 of 2,435 Results
-
Olivier Gevaert
Associate Professor of Medicine (Computational Medicine) and of Biomedical Data Science
Current Research and Scholarly InterestsMy lab focuses on biomedical data fusion: the development of machine learning methods for biomedical decision support using multi-scale biomedical data. We primarily use methods based on regularized linear regression to accomplish this. We primarily focus on applications in oncology and neuroscience.
-
Ishita Ghai
Postdoctoral Scholar, General Internal Medicine
BioIshita Ghai is a health policy researcher that applies causal inference methods to understand how health behaviors are shaped through individual and group factors in low-resource settings. She mainly studies these empirical questions in the context of randomized controlled trials, or through evaluations leveraging exogenous shocks using quasi-experimental techniques. She has managed several pilot and large randomized controlled trials across sub-Saharan Africa studying the short and long-term effects of health interventions on health outcomes for women, children, and people living with HIV/AIDS. At Stanford, she will advance work on medicine policy specifically focused on the effects of the shingles vaccine on dementia risk among older populations.
She completed her doctoral studies in policy analysis (economics concentration) at the RAND School of Public Policy, and holds an MBA from the University of California, Davis, an Ed.M. in international education policy from Harvard University, and a B.Tech in bioinformatics from VIT University. -
Zaniar Ghazizadeh
Instructor, Medicine - Cardiovascular Medicine
BioDr. Ghazizadeh is a Cardiac Electrophysiologist at Stanford. He completed his Internal Medicine residency at Yale before moving to Stanford to pursue fellowships in Cardiovascular Disease and Clinical Cardiac Electrophysiology.
Dr. Ghazizadeh's clinical interests focus on the management of complex cardiac arrhythmias. His research centers on developing computational and wet-lab platforms to study cardiac electrophysiology and the mechanisms underlying cardiac arrhythmias.
His work integrates a broad range of systems, including human biobanks, genetically engineered human and animal models, and nontraditional model organisms, to uncover the molecular and physiological basis of cardiac arrhythmias. His research has been supported by NIH, AHA, and several Stanford University funding programs. As a clinician-scientist, his long-term goal is to translate these discoveries into improved risk stratification tools and novel therapeutic strategies to prevent and treat cardiac arrhythmias. -
Sachi Gianchandani
Staff, Adult Neurology
Clinical Assistant Professor (Affiliated), Medicine - Primary Care and Population HealthBioSachi Gianchandani, MD, is a palliative care physician and neurologist at the VA Palo Alto Health Care System, where she provides comprehensive care for veterans. Her current roles include providing neuropalliative care in the ALS Interdisciplinary Clinic and attending on the inpatient palliative care, hospice, and neurology services.
She completed her medical school at Oakland University William Beaumont School of Medicine, neurology residency at The Ohio State University, and palliative care fellowship at Stanford Health Care. -
Karleen Giannitrapani
Assistant Professor of Medicine (Primary Care and Population Health)
BioIn contrast to bounded teams with static membership, dynamic teaming reflects the common challenge of interdisciplinary healthcare teams with changing rosters. Such dynamic collaboration is critical to addressing multi-faceted problems and individualizing care. At present, off the shelf interventions to improve the way healthcare teams work - often assume static and bounded teams. Dr Giannitrapani intends to leverage design approaches to build a new kind of healthcare “teaming intervention,” which respects the nature of their constantly changing membership and more closely aligns with how healthcare teams actually collaborate. Her expertise includes organizational behavior, building interdisciplinary teams, implementation science, mixed methods-research, quality improvement, pain and palliative care research, and global health.
In addition to the Assistant Professor role in Division of Primary Care and Population Health at Stanford University School of Medicine she serves as the quality lead for the section of Palliative Medicine. She is also a Core Investigator at the Center for Innovation to Implementation (Ci2i) in the VA Palo Alto Health Care System and serves as PI or co-investigator on multiple ongoing studies representing over 25 million dollars of competitive government grant funding. She is also a Director of the VA Quality Improvement Resource Center (QuIRC) for Palliative Care, supporting Geriatrics and Extended Care programs for 170 Veterans Affairs facilities nationally. In QuIRC she leads a portfolio of projects on improving the processes that interdisciplinary teams can leverage to improve pain and symptom management among high-risk patients; a specific focus of their work is to bridge the gap of poor palliative care integration in the perioperative period.
Dr Giannitrapani has given hundreds of presentations and have over 100 peer reviewed publications in high quality medical and health services delivery journals such as Medical Care, JAMA Surgery, the Journal of General Internal Medicine, the Journal of Pain and Symptom Management and Pain Medicine. She received a 5-year VA Career Development Award on building better teams across disciplines and was an American Academy of Hospice and Palliative Medicine Research Scholar for related work. -
Wil Gibb, MD
Clinical Assistant Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine
BioCritical care physician with a background in emergency medicine
-
Ruth Margaret Gibson
Visiting Scholar, Medicine - Primary Care and Population Health
BioDr. Ruth Gibson, PhD, is the founding Executive Director of the Stanford Geopolitical Human Impact Research Lab (Stanford Nenya). The lab examines how war, blockades, and sanctions affect human health, with particular attention to children. She is a visiting scholar at Stanford’s Center for Innovation in Global Health (CIGH) and an affiliated scholar at the Center for International Security and Cooperation (CISAC). She is co-leading the Lancet Series on Foreign Policy and Global Health in an Era of Geopolitical Crisis with Professor Gary Darmstadt. Through the Consortium of Universities for Global Health (CUGH) and Stanford’s CIGH, she convenes international panels on the health consequences of geopolitical crises. Before her academic career, Dr. Gibson spent a decade working in humanitarian and global health programs across eight countries on five continents, including active conflict zones. She is fluent in English and proficient in Mandarin Chinese (如詩 吉布森), French, and Spanish. She holds a PhD from the University of British Columbia, postdoctoral training from Stanford University, and an Honors Bachelor of Science and Master of Science from the University of Toronto. Her research has been published in The Lancet and The Lancet Global Health. Her work and commentary have been featured in The New York Times, The New Yorker, and TIME. She is available to journalists and media outlets seeking expert analysis on war, peace, and human health.
Contact: rmgibson@stanford.edu
Lab website: www.stanfordnenya.com -
Joshua Gillard
Postdoctoral Scholar, Cardiovascular Medicine
BioDr. Josh Gillard is a Canadian biomedical data scientist with experience in bioinformatics, machine learning, and immunology. After completing a BSc and a MSc in Experimental Medicine at McGill university, he relocated to the Netherlands for his PhD in bioinformatics at Radboud University in Nijmegen. During his PhD, he gained experience analyzing and interpreting complex immunological data (bulk and single-cell transcriptomics, high-dimensional cytometry, high-throughput proteomics) derived from human observational or intervention studies (vaccination and experimental human infection). This work revealed molecular and cellular correlates of clinically important endpoints such as disease severity, symptom progression, and antibody responses. In 2022, Josh relocated to Stanford to join the Gaudilliere lab to develop and apply multi-omic data integration and machine learning techniques, establishing that early gestational immune dysregulation can predict preterm birth. Since 2024, in the Ashley lab, Josh is developing deep learning models to investigate aberrant splicing in cardiovascular disease.
-
Christophe Gimmler, MD, MFT
Staff, Anesthesia - Department Operations
Clinical Assistant Professor (Affiliated), Medicine - Primary Care and Population HealthBioChristophe Gimmler, MD, MFT, Assistant Clinical Professor of Medicine (Affiliated) at Stanford School of Medicine;
Staff Physician, Medical Service, VA Palo Alto Health Care System;
Licensed Marriage and Family Therapist.
Associated Psychology Faculty, Palo Alto University
Clinical Monitor, Carhart-Harris Lab; Weill Institute for Neurosciences, UCSF
Study Physician, Open Mind Collective
_____________________________________________________________________________________________
After establishing and building the hospitalist and consult/liaison medicine service at the VA, Christophe now practices and teaches medical students and house staff in the primary care clinics there. He concurrently practices as a community psychotherapist and specializes in medical professionals. His central interest is the intersection of medicine and psychotherapy and, in particular, the application of psychological frameworks and skills to the practice of medicine, in addition to resiliency and burnout prevention. He developed the Medical Student Resiliency Skills Training program (MedReST) for the Stanford School of Medicine as well as the Resiliency Curriculum Series for the internal medicine residency program. He received as undergraduate degree in biology and psychology and an MD from the University of Virginia, completed his internal medicine residency at Stanford.
Christophe received a Master’s in Counseling Psychology from Sofia University. He has a private practice psychotherapy practice in Los Altos seeing adults and couples specializing in health care professionals (www.openpaththerapy.one). After completing a certificate in psychedelic-assisted psychotherapy at the Berkeley Center for the Science of Psychedelics, Christophe works as a Clinical Monitor at the Carhart-Harris Lab at UCSF and the Stanford Anesthesia Dream Project with the Heifets Lab, as well as a study physician at Open Mind Collective in San Francsico.
Publications:
Foster Well-being Throughout the Career Trajectory: A Developmental Model of Physician Resilience Training:
Mayo Clinic Proceedings
Cordova MJ, Gimmler CE, Osterberg LG
2020; 95 (12):
Developing institutional infrastructure for physician wellness: qualitative Insights from VA physicians.
BMC Health Services Research
Schwartz, R., Shanafelt, T. D., Gimmler, C., Osterberg, L.
2020; 20 (1): 7
Career-Long Skills for Personal and Professional Wellness: A Staged Developmental Model of Veterinarian Resilience Training.
J Vet Med Education
Cordova MJ, Gimmler C, Dibbern A, Duesterdieck-Zellmer KF.
2025 Apr 16 -
Diona Gjermeni
Affiliate, Med/Stanford Center for Clinical Research
BioDiona Gjermeni is a clinical physician with dual specialization in Internal Medicine and Cardiology (board certified in Germany). With a strong focus on clinical research and trials, her previous work primarily revolves around antithrombotic therapy, atrial fibrillation and precision medicine. Currently she is actively engaged as Research Fellow at the Stanford Center for Clinical Research (SCCR), where she is involved in a variety of cardiovascular clinical trials across multiple phases, with particular emphasis on digital health, heart failure, and cardiac arrhythmias. Her research aims to improve patient outcomes through innovative therapies and precision medicine.
-
Alan M Glaseroff
Other Teaching Staff-Hourly, Medicine - Primary Care and Population Health
BioDr. Alan Glaseroff served as the Director of Workforce Transformation in Primary Care at Stanford from the fall of 2015 until mid-June of 2016, where he was responsible for training the teams for Primary Care 2.0, a radical redesign of primary care underway in 2016. He will be joining the faculty at Stanford's Clinical Excellence Research Center this summer, working with Dr. Arnie Milstein to help develop new models of care. He formerly served as Co-Director of Stanford Coordinated Care, a service for patients with complex chronic illness from 2011 to the end of 2015. Dr. Glaseroff, a member of the Innovation Brain Trust for the UniteHERE Health, currently serves as faculty for the Institute of Healthcare Improvement’s “Better Care, Lower Cost” collaborative and served as a a Clinical Advisor to the PBGH “Intensive Outpatient Care Program” CMMI Innovation Grant that completes in June 2015. He served on the NCQA Patient-Centered Medical Home Advisory Committee 2009-2010, and the “Let’s Get Healthy California” expert task force in 2012,. Dr. Glaseroff was named the California Family Physician of the Year for 2009.
Dr. Glaseroff’s interests focus on the intersection of the meaning of patient-centered team care, patient activation, and the key role of self-management within the context of chronic conditions.
The Coordinated Care clinic is an exclusive benefit for eligible members of the Stanford University, Stanford Health Care, SLAC and Lucile Packard Children’s Hospital community and their covered adult dependents with ongoing health conditions.
Please complete the Coordinated Care self-assessment to determine eligibility based on health condition(s) and health insurance: https://stanfordmedicine.qualtrics.com/SE/?SID=SV_2siBNrfJ8zmn3GB -
Jeffrey S. Glenn, M.D., Ph.D.
Joseph D. Grant Professor and Professor of Microbiology and Immunology
Current Research and Scholarly InterestsDr. Glenn's primary interest is in molecular virology, with a strong emphasis on translating this knowledge into novel antiviral therapies. Other interests include exploitation of hepatic stem cells, engineered human liver tissues, liver cancer, and new biodefense antiviral strategies.
-
Thomas Glynn
Adjunct Lecturer, Medicine - Med/Stanford Prevention Research Center
BioBiosketch - Thomas J. Glynn, M.A., M.S., Ph.D. (psych.)
Dr. Glynn is, from 2014 to the present, Adjunct Lecturer, Stanford Prevention Research Center, Stanford University School of Medicine and Executive Team Member, Mayo Clinic Global Bridges Initiative. From 1998 to 2014, he was Director, Cancer Science and Trends and Director, International Cancer Control at the American Cancer Society (ACS). In these positions, he advised the ACS about emerging research and policy issues in cancer prevention and control, recommended cancer prevention and control research and policies, and participated in the development of an international cancer control program aimed at promoting cancer prevention-related research, advocacy, treatment, and policy change, particularly in middle- and low-income nations.
Prior to the ACS, Dr. Glynn was, from 1991 to 1994, Associate Director of the U.S. National Cancer Institute's (NCI) Cancer Control Science Program and, from 1991 to 1998, Chief of the NCI's Cancer Control Extramural Research Branch. There, he directed a national program of research aimed at reducing the incidence and prevalence of cancer, primarily through dietary change, tobacco use reduction, and adherence to cancer screening guidelines. From 1983 to 1991, he was Research Director for the NCI's Smoking, Tobacco, and Cancer Program and from 1978 to 1983, he was a Research Psychologist at the National Institute on Drug Abuse.
Dr. Glynn has published widely on cancer and tobacco use prevention and control, both in the scientific literature and for consumer, professional, and patient education and is co-developer of the 4A (now 5A) protocol for the treatment of tobacco dependence. In addition to his work at the ACS and NCI, he has served as a consultant on cancer control and tobacco issues to such groups as the National Academy of Sciences/Institute of Medicine, the National Research Council, the Robert Wood Johnson Foundation, the WHO, a variety of pharmaceutical organizations, and national, state and local governments.
He has also served as a Senior Scientific Reviewer for the U.S. Surgeon General's Reports on Tobacco and Health, as Director of the World Health Organization Study of Health, Economic, and Policy Implications of Tobacco Growth and Consumption in Developing Countries, and has been active in tobacco control programs in Eastern Europe, Central America, and India. He is a Fellow of the Society for Research on Nicotine and Tobacco and his awards include the U.S. National Institutes of Health Merit Award, the Polish Ministry of Health Service Award, the Guatemala National Council for Tobacco Prevention and Control Meritorious Service Award, the Society for Research on Nicotine and Tobacco John Slade Award, and the American Society of Preventive Oncology Joseph W. Cullen Memorial Award. -
Aparna Goel
Clinical Associate Professor, Medicine - Gastroenterology & Hepatology
Current Research and Scholarly InterestsDr. Goel is interested in studying the complications and management of patients with end-stage liver disease, including infections, bleeding and encephalopathy. As the waitlist for liver transplantation continues to grow, many patients develop consequences of decompensated liver disease. It is becoming increasingly important to improve our understanding and care of these complications in order to optimize the quality of life for this growing population of patients.
She is also particularly interested in the management of patients with autoimmune liver disease including autoimmune hepatitis, primary biliary cholangitis, primary sclerosing cholangitis among others.